Global Porcine Epidemic Diarrhea Vaccines Market Report 2025

Porcine Epidemic Diarrhea Vaccines Global Market Report 2025 – By Product (Live Vaccines, Killed Vaccines), By Application (Piglets, Adults Pigs), By End-User (Veterinary Hospitals, Hog Production Farms) – Market Size, Trends, And Global Forecast 2025-2034

Porcine Epidemic Diarrhea Vaccines Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Porcine Epidemic Diarrhea Vaccines Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Porcine Epidemic Diarrhea Vaccines Market Definition

Porcine epidemic diarrhea (PED) vaccines are biological preparations developed to provide immunity against the porcine epidemic diarrhea virus (PEDV), which causes severe gastrointestinal disease in pigs. These vaccines are essential tools in preventing and controlling Porcine Epidemic Diarrhea, contributing to the health and productivity of pig populations and the economic stability of the swine industry.

The main products of porcine epidemic diarrhea vaccines are live vaccines and killed vaccines. Live vaccines are biological preparations that contain attenuated or weakened forms of the porcine epidemic diarrhea virus (PEDV). The various applications include piglets, and adult pigs used in various end-users such as veterinary hospitals, and hog production farms.

Porcine Epidemic Diarrhea Vaccines Market Segmentation

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

Subsegments:

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

Porcine Epidemic Diarrhea Vaccines Market Size and growth rate 2025 to 2029: Graph

Porcine Epidemic Diarrhea Vaccines Market Size 2025 And Growth Rate

The porcine epidemic diarrhea vaccines market size has grown strongly in recent years. It will grow from $1.67 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to large-scale vaccination campaigns, expanded programs on immunization (EPI), the adoption of disposable syringes, diarrhea eradication efforts, and initiatives like the global alliance for vaccines and immunization (GAVI).

Porcine Epidemic Diarrhea Vaccines Market Growth Forecast

The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pig populations, focus on cold chain management, and rising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, growing preference for self-administered vaccines, and strengthening animal healthcare infrastructure and distribution networks.

Porcine Epidemic Diarrhea Vaccines Market Driver: Driving Factors Behind The Growth Of Porcine Epidemic Diarrhea Vaccines Market

The increasing pig farming is expected to propel the growth of the porcine epidemic diarrhea vaccine market going forward. Pig farming involves raising domestic pigs for meat production, breeding, rearing, managing from birth to market weight, and marketing and selling pork products. Pig farming is increasing due to rising global demand for pork products, improvements in breeding and management practices, technological advancements in farming techniques, and expanding markets for pork consumption. Porcine epidemic diarrhea (PED) vaccines are employed in pig farming to prevent and manage outbreaks. They are usually administered via injection or orally starting from the sow's gestation period to confer passive immunity to newborn piglets through colostrum. For instance, according to the United States Department of Agriculture, a US-based government department, in 2022, pork production in the United States reached 40.6 billion pounds, marking a 1 percent increase compared to the previous year. Therefore, the increasing pig farming is driving the growth of the porcine epidemic diarrhea vaccine market.

Global Porcine Epidemic Diarrhea Vaccines Market Major Players

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc

Global Porcine Epidemic Diarrhea Vaccines Market Trend: Innovative Porcine Parvovirus (PPV) Vaccines To Combat Reproductive Failure In Pigs

Major companies operating in the porcine epidemic diarrhea vaccines market are developing innovative products, such as the porcine parvovirus (PPV) vaccine, to strengthen their position in the market. The Porcine Parvovirus (PPV) vaccine is a veterinary immunization designed to prevent reproductive failure in pigs caused by PPV, a small, non-enveloped virus associated with infertility, stillbirths, mummified fetuses, and weak piglets. For instance, in March 2022, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched the ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine. This innovative vaccine is designed to combat reproductive failure in pigs, including infertility, stillbirths, mummified fetuses, and weak piglets caused by PPV, a small, non-enveloped virus. The uniqueness of this launch lies in the advanced formulation and efficacy of the vaccine, which offers comprehensive protection against PPV-induced reproductive losses, thereby safeguarding the health and productivity of pig herds.

Porcine Epidemic Diarrhea Vaccines Market Merger And Acquisition: Phibro Animal Health Corporation Acquires Zoetis Inc. to Expand Animal Health and Nutrition Portfolio

In November 2024, Phibro Animal Health Corporation, a US-based health company, acquired Zoetis Inc. for an undisclosed amount. The acquisition aims to broaden Phibro’s product portfolio in medicated feed additives and water-soluble products for cattle, swine, and poultry, strengthening its ability to support animal health and nutrition worldwide. It also seeks to increase Phibro’s profitability, expand its revenue base, and provide funding for future investments in the animal health sector. Zoetis Inc. is a pharmaceutical manufacturing company that specializes in manufacturing of porcine epidemic diarrhea vaccines.

Regional Outlook For The Global Porcine Epidemic Diarrhea Vaccines Market

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the porcine epidemic diarrhea vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Porcine Epidemic Diarrhea Vaccines Market?

The porcine epidemic diarrhea vaccines market consists of sales of ingelvac PEDV, barricade, PED vax, PEDV shield, and enterisol ileitis. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Porcine Epidemic Diarrhea Vaccines Industry?

The porcine epidemic diarrhea vaccines market research report is one of a series of new reports from The Business Research Company that provides porcine epidemic diarrhea vaccines market statistics, including porcine epidemic diarrhea vaccines industry global market size, regional shares, competitors with a porcine epidemic diarrhea vaccines market share, detailed porcine epidemic diarrhea vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the porcine epidemic diarrhea vaccines industry. This porcine epidemic diarrhea vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Porcine Epidemic Diarrhea Vaccines Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $1.8 billion
Revenue Forecast In 2034 $2.42 billion
Growth Rate CAGR of 7.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms Subsegments: 1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Porcine Epidemic Diarrhea Vaccines Market Characteristics

    3. Porcine Epidemic Diarrhea Vaccines Market Trends And Strategies

    4. Porcine Epidemic Diarrhea Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Porcine Epidemic Diarrhea Vaccines Growth Analysis And Strategic Analysis Framework

    5.1. Global Porcine Epidemic Diarrhea Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Porcine Epidemic Diarrhea Vaccines Market Growth Rate Analysis

    5.4. Global Porcine Epidemic Diarrhea Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Porcine Epidemic Diarrhea Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Porcine Epidemic Diarrhea Vaccines Total Addressable Market (TAM)

    6. Porcine Epidemic Diarrhea Vaccines Market Segmentation

    6.1. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Live Vaccines

    Killed Vaccines

    6.2. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Piglets

    Adults Pigs

    6.3. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Veterinary Hospitals

    Hog Production Farms

    6.4. Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral Live Vaccines

    Injectable Live Vaccines

    6.5. Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Killed Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Inactivated Injectable Vaccines

    Inactivated Oral Vaccines

    7. Porcine Epidemic Diarrhea Vaccines Market Regional And Country Analysis

    7.1. Global Porcine Epidemic Diarrhea Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Porcine Epidemic Diarrhea Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market

    8.1. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Porcine Epidemic Diarrhea Vaccines Market

    9.1. China Porcine Epidemic Diarrhea Vaccines Market Overview

    9.2. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Porcine Epidemic Diarrhea Vaccines Market

    10.1. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Porcine Epidemic Diarrhea Vaccines Market

    11.1. Japan Porcine Epidemic Diarrhea Vaccines Market Overview

    11.2. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Porcine Epidemic Diarrhea Vaccines Market

    12.1. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Porcine Epidemic Diarrhea Vaccines Market

    13.1. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Porcine Epidemic Diarrhea Vaccines Market

    14.1. South Korea Porcine Epidemic Diarrhea Vaccines Market Overview

    14.2. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Porcine Epidemic Diarrhea Vaccines Market

    15.1. Western Europe Porcine Epidemic Diarrhea Vaccines Market Overview

    15.2. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Porcine Epidemic Diarrhea Vaccines Market

    16.1. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Porcine Epidemic Diarrhea Vaccines Market

    17.1. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Porcine Epidemic Diarrhea Vaccines Market

    18.1. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Porcine Epidemic Diarrhea Vaccines Market

    19.1. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Porcine Epidemic Diarrhea Vaccines Market

    20.1. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market

    21.1. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market Overview

    21.2. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Porcine Epidemic Diarrhea Vaccines Market

    22.1. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Porcine Epidemic Diarrhea Vaccines Market

    23.1. North America Porcine Epidemic Diarrhea Vaccines Market Overview

    23.2. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Porcine Epidemic Diarrhea Vaccines Market

    24.1. USA Porcine Epidemic Diarrhea Vaccines Market Overview

    24.2. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Porcine Epidemic Diarrhea Vaccines Market

    25.1. Canada Porcine Epidemic Diarrhea Vaccines Market Overview

    25.2. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Porcine Epidemic Diarrhea Vaccines Market

    26.1. South America Porcine Epidemic Diarrhea Vaccines Market Overview

    26.2. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Porcine Epidemic Diarrhea Vaccines Market

    27.1. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Porcine Epidemic Diarrhea Vaccines Market

    28.1. Middle East Porcine Epidemic Diarrhea Vaccines Market Overview

    28.2. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Porcine Epidemic Diarrhea Vaccines Market

    29.1. Africa Porcine Epidemic Diarrhea Vaccines Market Overview

    29.2. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Porcine Epidemic Diarrhea Vaccines Market Competitive Landscape And Company Profiles

    30.1. Porcine Epidemic Diarrhea Vaccines Market Competitive Landscape

    30.2. Porcine Epidemic Diarrhea Vaccines Market Company Profiles

    30.2.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Merck Animal Health Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Elanco Animal Health Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Idexx Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Porcine Epidemic Diarrhea Vaccines Market Other Major And Innovative Companies

    31.1. Ceva Santé Animale Health Company

    31.2. Phibro Animal Health Corporation

    31.3. Benchmark Animal Health Ltd.

    31.4. IDT Biologika GmbH

    31.5. Vaxxinova

    31.6. Qilu Animal Health Products Factory Co. Ltd.

    31.7. Tecnovax

    31.8. Green Cross Veterinary Products Co. Ltd.

    31.9. Nisseiken Co. Ltd.

    31.10. Komipharm International Co. Ltd.

    31.11. Boehringer Ingelheim Animal Health

    31.12. MSD Animal Health

    31.13. Ourofino Saúde Animal

    31.14. Medgene Labs

    31.15. Harrisvaccines Inc

    32. Global Porcine Epidemic Diarrhea Vaccines Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Porcine Epidemic Diarrhea Vaccines Market

    34. Recent Developments In The Porcine Epidemic Diarrhea Vaccines Market

    35. Porcine Epidemic Diarrhea Vaccines Market High Potential Countries, Segments and Strategies

    35.1 Porcine Epidemic Diarrhea Vaccines Market In 2029 - Countries Offering Most New Opportunities

    35.2 Porcine Epidemic Diarrhea Vaccines Market In 2029 - Segments Offering Most New Opportunities

    35.3 Porcine Epidemic Diarrhea Vaccines Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Killed Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Porcine Epidemic Diarrhea Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Porcine Epidemic Diarrhea Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Zoetis Inc. Financial Performance
  • Table 77: Merck Animal Health Financial Performance
  • Table 78: Elanco Animal Health Financial Performance
  • Table 79: Idexx Laboratories Inc. Financial Performance
  • Table 80: Bio-Rad Laboratories Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Killed Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Porcine Epidemic Diarrhea Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Porcine Epidemic Diarrhea Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Zoetis Inc. Financial Performance
  • Figure 77: Merck Animal Health Financial Performance
  • Figure 78: Elanco Animal Health Financial Performance
  • Figure 79: Idexx Laboratories Inc. Financial Performance
  • Figure 80: Bio-Rad Laboratories Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Porcine Epidemic Diarrhea Vaccines market?

Porcine epidemic diarrhea (PED) vaccines are biological preparations developed to provide immunity against the porcine epidemic diarrhea virus (PEDV), which causes severe gastrointestinal disease in pigs. These vaccines are essential tools in preventing and controlling Porcine Epidemic Diarrhea, contributing to the health and productivity of pig populations and the economic stability of the swine industry. For further insights on the Porcine Epidemic Diarrhea Vaccines market, request a sample here

How will the Porcine Epidemic Diarrhea Vaccines market drivers and restraints affect the market dynamics? What forces will shape the Porcine Epidemic Diarrhea Vaccines industry going forward?

The Porcine Epidemic Diarrhea Vaccines market major growth driver - Driving Factors Behind The Growth Of Porcine Epidemic Diarrhea Vaccines Market. For further insights on the Porcine Epidemic Diarrhea Vaccines market, request a sample here

What is the forecast market size or the forecast market value of the Porcine Epidemic Diarrhea Vaccines market?

The Porcine Epidemic Diarrhea Vaccines market size has grown strongly in recent years. The porcine epidemic diarrhea vaccines market size has grown strongly in recent years. It will grow from $1.67 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to large-scale vaccination campaigns, expanded programs on immunization (EPI), the adoption of disposable syringes, diarrhea eradication efforts, and initiatives like the global alliance for vaccines and immunization (GAVI). The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pig populations, focus on cold chain management, and rising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, growing preference for self-administered vaccines, and strengthening animal healthcare infrastructure and distribution networks. For further insights on the Porcine Epidemic Diarrhea Vaccines market, request a sample here

How is the Porcine Epidemic Diarrhea Vaccines market segmented?

The porcine epidemic diarrhea vaccines market covered in this report is segmented –
1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms
Subsegments:
1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines For further insights on the Porcine Epidemic Diarrhea Vaccines market,
request a sample here

Which region has the largest share of the Porcine Epidemic Diarrhea Vaccines market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Porcine Epidemic Diarrhea Vaccines market, request a sample here.

Who are the major players in the Porcine Epidemic Diarrhea Vaccines market?

Major companies operating in the porcine epidemic diarrhea vaccines market are developing innovative products, such as the porcine parvovirus (PPV) vaccine, to strengthen their position in the market. The Porcine Parvovirus (PPV) vaccine is a veterinary immunization designed to prevent reproductive failure in pigs caused by PPV, a small, non-enveloped virus associated with infertility, stillbirths, mummified fetuses, and weak piglets. For instance, in March 2022, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched the ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine. This innovative vaccine is designed to combat reproductive failure in pigs, including infertility, stillbirths, mummified fetuses, and weak piglets caused by PPV, a small, non-enveloped virus. The uniqueness of this launch lies in the advanced formulation and efficacy of the vaccine, which offers comprehensive protection against PPV-induced reproductive losses, thereby safeguarding the health and productivity of pig herds.. For further insights on the Porcine Epidemic Diarrhea Vaccines market, request a sample here.

What are the key trends in the Porcine Epidemic Diarrhea Vaccines market?

Major trends in the Porcine Epidemic Diarrhea Vaccines market include Innovative Porcine Parvovirus (PPV) Vaccines To Combat Reproductive Failure In Pigs. For further insights on the Porcine Epidemic Diarrhea Vaccines market, request a sample here.

What are the major opportunities in the Porcine Epidemic Diarrhea Vaccines market? What are the strategies for the Porcine Epidemic Diarrhea Vaccines market?

For detailed insights on the major opportunities and strategies in the Porcine Epidemic Diarrhea Vaccines market, request a sample here.

How does the Porcine Epidemic Diarrhea Vaccines market relate to the overall economy and other similar markets?

For detailed insights on Porcine Epidemic Diarrhea Vaccines's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Porcine Epidemic Diarrhea Vaccines industry?

For detailed insights on the mergers and acquisitions in the Porcine Epidemic Diarrhea Vaccines industry, request a sample here.

What are the key dynamics influencing the Porcine Epidemic Diarrhea Vaccines market growth? SWOT analysis of the Porcine Epidemic Diarrhea Vaccines market.

For detailed insights on the key dynamics influencing the Porcine Epidemic Diarrhea Vaccines market growth and SWOT analysis of the Porcine Epidemic Diarrhea Vaccines industry, request a sample here.